Invasive hemodynamic monitoring-guided resuscitation improves survival in shock: A systematic review and meta-analysis
Advanced monitoring of heart function during critical illness cuts death rates by a third, with largest evidence from catheter-guided resuscitation.
A large meta-analysis (34 studies, n=636,441 shock patients) finds that advanced hemodynamic monitoring-guided resuscitation is associated with 34% lower in-hospital mortality overall and 32% lower mortality in cardiogenic shock specifically, with greatest evidence from PAC-guided therapy. The magnitude of benefit and the dataset size are impressive, though high heterogeneity across shock types and monitoring methods warrants cautious interpretation.
What the study was
- Study design
- Systematic review and meta-analysis (34 studies including 7 RCTs, random-effects model; PROSPERO CRD42024607758)
- Population
- Adult shock patients (any shock type) across multiple healthcare settings; n=636,441
- Sample size
- 636441
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Annals of Intensive Care
Why it surfaced
UNSOLICITED FIND: Meta-analysis with n=636,441 patients demonstrating 34% mortality reduction with invasive hemodynamic monitoring in shock; cardiogenic shock benefit from PAC-guided therapy particularly striking (OR 0.68); high clinical impact outside core watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.